![Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial - Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial -](https://www.thelancet.com/cms/attachment/f470125a-7816-4234-aac2-7db9b5683965/gr1_lrg.jpg)
Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial -
![World Health Organization (WHO) on Twitter: "🚨 GAME CHANGER 🚨 One-dose Human Papillomavirus (#HPV) vaccine offers solid protection against cervical cancer: WHO https://t.co/3uWlZlCCVK https://t.co/ZKDvpf2qog" / Twitter World Health Organization (WHO) on Twitter: "🚨 GAME CHANGER 🚨 One-dose Human Papillomavirus (#HPV) vaccine offers solid protection against cervical cancer: WHO https://t.co/3uWlZlCCVK https://t.co/ZKDvpf2qog" / Twitter](https://pbs.twimg.com/media/FQEmye1XMAsLUh0.jpg)
World Health Organization (WHO) on Twitter: "🚨 GAME CHANGER 🚨 One-dose Human Papillomavirus (#HPV) vaccine offers solid protection against cervical cancer: WHO https://t.co/3uWlZlCCVK https://t.co/ZKDvpf2qog" / Twitter
![PDF] Technical synthesis of the current published evidence for single-dose HPV vaccination | Semantic Scholar PDF] Technical synthesis of the current published evidence for single-dose HPV vaccination | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b5941e2cb226b11bcade429189df006afa13a937/2-Table1-1.png)